
Today’s health summary covers Ebola preparations at a hospital in northern Nigeria, a scabies outbreak at a hospital in Swansea, the measles outbreak in Pennsylvania’s Amish country, a trial that put young adults’ type 2 diabetes into remission with diet and exercise, and nanoparticle cancer vaccines tested in mice.
Nigerian hospital readies its isolation unit for possible Ebola cases
A federal hospital in northern Nigeria has strengthened its isolation unit and put emergency measures in place after the national government told health facilities across the country to prepare for possible Ebola cases. Dr Yunus Mohammed Eze, deputy head of clinical services at the Federal Medical Centre in Birnin Kudu, Jigawa State, said no case had been recorded at the hospital or anywhere in the state, but staff had been put on alert to spot and isolate suspected patients quickly.
Eze said the directive, passed on by the Federal Ministry of Health, asked hospitals to ready their isolation units and to make sure protective equipment and medical supplies were available for staff and patients. Suspected or confirmed cases would be referred to designated treatment centres when needed. The hospital is also running health education through its infectious diseases and community medicine units, and works with the state media corporation on public awareness programmes about preventing disease.
The same hospital is already dealing with diphtheria, as an outbreak centred on Kano State has spread into Jigawa. Eze said it had treated four cases this month in its isolation unit, three of whom recovered and went home while one died, and that staff who cared for them were being monitored. Diphtheria is a bacterial infection that can block the airway and is preventable with a vaccine, and he urged parents to keep their children’s routine immunisations up to date.
Swansea hospital restricts visits after a scabies outbreak
A hospital in Swansea has brought in visiting restrictions after confirming an outbreak of scabies, a highly contagious skin infestation. The local health board, responsible for Swansea and Neath Port Talbot, said a small number of cases had been found at Morriston Hospital, families had been told, and treatment or guidance had been given to the patients, staff and relatives involved. It advised anyone worried that they might have the condition to seek help from a pharmacy or GP.
It is the latest in a run of cases in Welsh hospitals. An outbreak was recorded at Prince Philip Hospital in Llanelli last month, and on 20 October Hywel Dda Health Board shut the Cadog and Dewi wards at Glangwili General Hospital in Carmarthen to new patients and visitors as a precaution, saying the risk to the wider public was low. A ward at Glangwili had also been hit in July by crusted scabies, a rare and severe form of the condition.
Scabies is caused by tiny mites that burrow into the skin to live and lay eggs, and the itching and pimple-like rash come from an allergic reaction to them. It spreads mainly through long periods of close skin contact and is a particular problem in crowded settings such as care homes, schools, prisons and hospitals. The rash often appears between the fingers, around the wrists and along the waist, and the itch tends to be worse at night. First-time infections usually cause symptoms within three weeks.
Measles outbreak in Pennsylvania’s Amish country prompts more interest in vaccines
Lancaster County in Pennsylvania, home to the largest Amish population in the United States, is at the centre of the country’s worst measles outbreak in 35 years, and some members of its Plain communities are now showing more willingness to be vaccinated. Pennsylvania has recorded more than 1,350 cases this year, over a third of them in Lancaster County, although community leaders believe the true figure is much higher because many people with measles never see a doctor.
The state has recorded three deaths linked to measles in Lancaster and two in other counties. A local non-profit clinic has given about 450 measles shots through small vaccination events aimed at Amish and conservative Mennonite families, and is offering infants doses earlier than usual. Experts say low uptake among the Amish stems more from habit and culture than from religious doctrine, and stress that the outbreak also threatens the wider population, whose vaccination rates are falling too.
Nationally, 92.4% of kindergarten children received the required MMR vaccine in 2025-26, down from 95.2% in 2019-20, while an outbreak is considered unlikely where coverage reaches 95%. Pennsylvania’s kindergarten rate fell to 93.2% last year and Lancaster County’s stands at 88%. Measles is a highly contagious airborne disease that spreads through coughs and sneezes, and infected people can pass it on from four days before until four days after the rash appears.
Diet and exercise put more than half of young adults’ type 2 diabetes into remission
Over half of the young adults with type 2 diabetes who completed a supervised programme combining a very low-calorie diet with exercise went into remission within six months, according to a trial presented at this year’s congress of Europe’s leading diabetes association. In the RESET for Remission study, 27 of the 50 people in the intensive programme reached remission after 24 weeks, compared with two of the 46 who received usual care.
Participants were aged 18 to 45, had obesity and early-onset diabetes, and were recruited at three centres in England and Canada. They stopped glucose-lowering medication under medical supervision, ate 800 to 900 calories a day for 12 weeks and did supervised aerobic and resistance training twice a week. The intensive group lost about 8.4 kilograms on average while largely keeping their muscle, and the researchers calculated that people in the programme were 21 times more likely to reach remission.
Remission here meant an HbA1c reading below 6.5% after at least 12 weeks without diabetes drugs, and experts stress that it is not a cure, since blood sugar can rise again if weight returns. Side effects such as constipation and headaches were common early on, and people should not try such a diet or stop medication without a doctor’s guidance. Type 2 diabetes accounts for about 90% of all diabetes cases and mainly results from obesity and a lack of exercise.
MIT nanoparticles show promise for personalised cancer vaccines in mice
Researchers at the Massachusetts Institute of Technology have developed a customisable nanoparticle that could carry personalised cancer vaccines, and in tests on mice it protected against melanoma and colon tumours. The vaccine is built on M13, a modified bacteriophage that is harmless to humans and forms a long nanofibre that can be coated with cancer antigens. By controlling how densely those antigens are packed on its surface, the team created a version that stopped colon tumours developing in the animals.
Lead author Shengnan Huang found that adding one or two negatively charged amino acids to a coat protein raised the antigen density, which could be tuned from 6% to 70%. In mice, a vaccine at 35% density protected better than one at 6%, and the animals produced more T cells against the target. The phage’s own DNA also acts as an adjuvant, so no separate ingredient is needed. The work appears in the journal Advanced Healthcare Materials, with Angela Belcher as senior author.
Belcher’s laboratory has worked with the M13 phage for more than 20 years, previously engineering it to assemble scaffolds for batteries, solar cells and catalysts. The virus infects the bacterium Escherichia coli and consists of a single strand of DNA wrapped in a coat made of about 2,700 copies of one protein. Because different antigens can be swapped in, the team hopes the platform could be adapted to individual patients’ tumours and to other cancers, though so far it has been tested only in animals.